Results 241 to 250 of about 2,250,906 (262)

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Compound screening in primary human airway basal cells identifies Wnt pathway activators as potential pro-regenerative therapies

Ishii Y, Orr JC, El Mdawar M, de Pilger DRB, Pearce DR, Lazarus KA, Graham RE, Nikolić MZ, Ketteler R, Carragher NO, Janes SM, Hynds RE.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Social determinants of health and US cancer screening interventions: A systematic review

Ca-A Cancer Journal for Clinicians, 2023
Ariella R Korn, Karen Maria Emmons, Callie Walsh-Bailey   +2 more
exaly  

Time to add screening for financial hardship as a quality measure?

Ca-A Cancer Journal for Clinicians, 2021
Ya-Chen Tina Shih, Cathy J Bradley, Syed Yousuf Zafar   +2 more
exaly  

Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2019
Stacey A Fedewa, Richard C Wender, Robert A Smith   +2 more
exaly  

Cancer screening in the United States, 2013†

Ca-A Cancer Journal for Clinicians, 2013
Robert A Smith, Otis Brawley, Durado Brooks   +2 more
exaly  

Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2017
Stacey A Fedewa, Richard C Wender, Robert A Smith   +2 more
exaly  

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

Ca-A Cancer Journal for Clinicians, 2020
Carmen E Guerra, Ya-Chen Tina Shih, Richard C Wender   +2 more
exaly  

Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2016
Stacey A Fedewa, Richard C Wender, Joannie Lortet-Tieulent   +2 more
exaly  

Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2018
Stacey A Fedewa, Richard C Wender, Robert A Smith   +2 more
exaly